Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Armen A. Ovsepyan"'
Autor:
G. B. Telegin, Sergey A. Kozin, Philipp O. Tsvetkov, Andrey Lisitsa, Armen A. Ovsepyan, I. B. Cheglakov, Alexander A. Makarov
Publikováno v:
Neurotoxicity Research. 24:370-376
Intracerebral and intraperitoneal inoculation with β-amyloid-rich brain extracts originating from patients with Alzheimer's disease as well as intracerebral injection of aggregates composed of synthetic Aβ can induce cerebral β-amyloidosis, and as
Autor:
A.V. Eremeev, Andrey P. Karpov, Armen A. Ovsepyan, Charles A. Nicolette, Olga A. Zubkova, Elmira Zeynalova, Vilena Ivanova, Sergey V. Ruchko, Alexander M. Shuster, Maxim V. Lykov, L. S. Agapova
Publikováno v:
Journal of Clinical Oncology. 36:31-31
31 Background: AGS-003 is an immunotherapy consisting of autologous dendritic cells electroporated with amplified total tumor RNA plus synthetic CD40L RNA and is currently being tested in combination with standard of care to extend survival of newly
Autor:
Georgy B. Telegin, Ivan B. Cheglakov, Sergey A. Kozin, Alexander Morozov, Philipp O. Tsvetkov, Oleg Mediannikov, Armen A. Ovsepyan
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, IOS Press, 2016, pp.20-20. ⟨10.3233/JAD-150031⟩
Journal of Alzheimer's Disease, IOS Press, 2016, pp.20-20. ⟨10.3233/JAD-150031⟩
International audience; Two tetrapeptides, HAEE and RADD, which are ionic-complementary to the primary zinc recognition site of amyloid-(A), have been reported to inhibit zinc-induced dimerization of the A metal-binding domain and slow A aggregation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b96531029fabe6eac5eac9353d41c3b6
https://doi.org/10.3233/JAD-150031
https://doi.org/10.3233/JAD-150031
Autor:
Armen A. Ovsepyan, G. B. Telegin, Alexander A. Makarov, Philippe O. Tsvetkov, Ivan B. Cheglakov, Sergey A. Kozin, Andrey Lisitsa
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
Marina V. Kapralova, Andrey P. Karpov, A.V. Eremeev, Vladimir Bokovanov, L. S. Agapova, Armen A. Ovsepyan, Olga V. Grigoryeva, Maxim V. Lykov, Olga A. Zubkova, Liudmila A. Krasovskaia, Charles A. Nicolette, Sergey V. Ruchko, Alexander M. Shuster
Publikováno v:
Journal of Clinical Oncology. 34:e14532-e14532
e14532Background: AGS-003 is an immunotherapy consisting of autologous dendritic cells electroporated with amplified total tumor RNA plus synthetic CD40L RNA and is currently being tested in combin...